The table below shows CYTOKINETICS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$145.46M
-$131.62M
-$129.51M
-$122.29M
-$26.81M
-$29.52M
Capital expenditure
$5.93M
$5.66M
$0.00
$402.00K
$942.00K
$6.63M
Investing cash flow
$145.49M
$105.96M
$32.64M
$165.50M
-$64.28M
-$5.28M
Dividends paid
-
-
-
-
CYTK operating cash flow (10-K history)
CYTOKINETICS INC reported operating cash flow of -$510.01M for fiscal year 2025. That is down 28.8% from -$395.89M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$7.72M (FY 2013) to -$510.01M. Figures come from the company's audited annual reports as filed with the SEC.
